GIMV (GIMV)

Brussels
Currency in EUR
38.65
+0.70(+1.84%)
Closed
GIMV Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
Day's Range
38.2038.65
52 wk Range
35.8547.10
Key Statistics
Edit
Prev. Close
38.65
Open
38.2
Day's Range
38.2-38.65
52 wk Range
35.85-47.1
Volume
35.36K
Average Volume (3m)
43.79K
1-Year Change
-14.11%
Book Value / Share
55.62
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GIMV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
50.63
Upside
+31.00%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
No news in this category
Looks like there are no results in this news category

GIMV Company Profile

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering, advanced manufacturing or software. It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia and invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany. It typically makes investments between €5 million ($5.43 million) to €75 million ($81.53 million) in consumer, health care, smart industries and sustainable client sector. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.

Compare GIMV to Peers and Sector

Metrics to compare
GIMV
Peers
Sector
Relationship
P/E Ratio
6.7x10.6x8.9x
PEG Ratio
0.500.010.03
Price/Book
0.9x1.0x1.0x
Price / LTM Sales
5.0x6.0x2.7x
Upside (Analyst Target)
45.3%23.5%18.1%
Fair Value Upside
Unlock22.1%3.5%Unlock

Analyst Ratings

2 Buy
1 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 50.63
(+31.00% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.25
Dividend Yield
4.80%
Industry Median 4.98%
Annualised payout
1.82
Paid annually
5-Years Growth
+0.79%
Growth Streak

Earnings

Latest Release
Feb 20, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

68.88
SYENS
+0.42%
65.90
MONTE
+0.15%
123.20
HLAN
-0.48%
36.460
JUNG_p
+3.82%
135.20
DEME
+1.50%

FAQ

What Is the GIMV (GIMV) Stock Price Today?

The GIMV stock price today is 38.65

What Stock Exchange Does GIMV Trade On?

GIMV is listed and trades on the Brussels stock exchange.

What Is the Stock Symbol for GIMV?

The stock symbol for GIMV is "GIMV."

What Is the GIMV Market Cap?

As of today, GIMV market cap is 1.38B.

What is GIMV Earnings Per Share?

The GIMV EPS is 7.25.

From a Technical Analysis Perspective, Is GIMV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.